SOMERVILLE, Mass. - bluebird bio, Inc. (NASDAQ: BLUE), a leader in gene therapy currently valued at $39 million, along with investment firms Carlyle (NASDAQ: CG) and SK Capital Partners ...

Lana Del Rey, “Bluebird” Madison McFerrin, “I Don’t” Grumpy featuring claire rousay and Pink Must, “Harmony” Jon Pareles has been The Times’s chief pop music critic since 1988.

A new fine dining restaurant on the Eastern Shore is slated to open from the co-owners of Bluebird Cocktail Room in Baltimore. Husband-and-wife team chef Paul Edward, formerly known as Paul ...

The Bluebird Theater may not immediately spring to mind. It’s not that fancy, nor that big. But its history says reams about the Mile High City. The gorgeous, blue-neon sign jumps out from its ...

The singer's latest single brought in 62% of the vote. By Mitchell Peters Lana Del Rey‘s “Bluebird” tops this week’s new music poll. In a poll published Friday (April 18) on Billboard ...

Lana Del Rey dropped her new country-tinged single “Bluebird” on Friday and shared a story about how the song was inspired by a real-life bird that brought her a sign she should have listened to.

By Ashley Iasimone Lana Del Rey‘s newest release, the lullaby-like “Bluebird” just released on Friday (April 18), is a song that’s been years in the making. The ballad first came to her ...

Now, she’s unveiling “Bluebird.” The LP was originally slated for release by the end of 2024, and then it was set for May 21. We don’t know when it’s coming, nor do we know its new title.

(RTTNews) - Bluebird bio, Inc. (BLUE), the Massachusetts based biotechnology company, on Wednesday announced that after three weeks of discussions and an extended deadline Ayrmid Ltd. has not made ...

bluebird Board reaffirms unanimous recommendation in support of transaction with Carlyle and SK Capital and recommends all stockholders tender into the current agreement by May 2, 2025 SOMERVILLE ...

Ayrmid proposed acquiring Bluebird for $4.50 per share in cash plus a $6.84 per share contingent value right based on a net sales milestone. Bluebird previously agreed to a $3.00 per share buyout ...

Bluebird Bio has received a competing bid from Ayrmid to buy the cash-strapped gene-therapy company in a deal potentially valued at up to $110.5 million. Bluebird said late Friday that Ayrmid made ...